Cargando…
Hepatotoxicity in hyperthyroid patient after consecutive methimazole and propylthiouracil therapies
Methimazole (MMI) and propylthiouracil (PTU) are widely used antithyroid drugs (ATD) that have been approved for the treatment of hyperthyroidism. Hepatotoxicity may be induced by these drugs, though they exert dissimilar incidence rates of hepatotoxicity and, possibly, with different underlying pat...
Autores principales: | Gomez-Peralta, Fernando, Velasco-Martínez, Pablo, Abreu, Cristina, Cepeda, María, Fernández-Puente, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763277/ https://www.ncbi.nlm.nih.gov/pubmed/29340156 http://dx.doi.org/10.1530/EDM-17-0173 |
Ejemplares similares
-
Methimazole-induced myositis: a case report and review of the literature
por: Bou Khalil, R, et al.
Publicado: (2013) -
A case of thyroid storm complicated by acute hepatitis due to propylthiouracil treatment
por: Tufton, Nicola, et al.
Publicado: (2015) -
Takotsubo cardiomyopathy in amiodarone-induced hyperthyroidism
por: Capel, Ismael, et al.
Publicado: (2017) -
High-dose intravenous hydrocortisone for the treatment of hyperthyroidism: a rare precipitant of thyrotoxicosis periodic paralysis
por: Scheive, Melanie, et al.
Publicado: (2023) -
The efficiency and safety of methimazole and propylthiouracil in hyperthyroidism: A meta-analysis of randomized controlled trials
por: Tan, Shuang, et al.
Publicado: (2021)